Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Müller-Berghaus, J; Ehlert, K; Ugurel, S; Umansky, V; Bucur, M; Schirrmacher, V; Beckhove, P; Schadendorf, D.
Melanoma-reactive T cells in the bone marrow of melanoma patients: association with disease stage and disease duration.
Cancer Res. 2006; 66(12):5997-6001
Doi: 10.1158/0008-5472.CAN-04-0484
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-Autor*innen der Med Uni Graz
-
Ugurel-Becker Selma
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Using IFN-gamma enzyme-linked immunospot, we investigated reactivity of T cells from bone marrow and peripheral blood to melanoma lysate-pulsed autologous dendritic cells in 40 melanoma patients. Melanoma-reactive T cells were present in the bone marrow of seven patients and in peripheral blood of four patients. In the bone marrow, melanoma-reactive T cells were present in 6 of 21 stage IV patients and in 1 of 10 stage III patients, whereas none were detected in stage I to II patients (0 of 9). The occurrence of tumor-reactive bone marrow T cells in melanoma patients was associated with advanced disease stage, disease duration and tumor load, and independent of treatment. These findings provide new insights into the generation of T-cell responses in melanoma patients.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adult -
-
Aged -
-
Bone Marrow Cells - immunology Bone Marrow Cells - pathology
-
Dendritic Cells - immunology
-
Female -
-
Humans -
-
Immunotherapy, Adoptive - methods
-
Interferon-gamma - biosynthesis Interferon-gamma - immunology
-
Male -
-
Melanoma - immunology Melanoma - pathology Melanoma - therapy
-
Middle Aged -
-
Neoplasm Staging -
-
T-Lymphocytes - immunology T-Lymphocytes - pathology